Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 8, Pages 1766
Publisher
MDPI AG
Online
2020-07-23
DOI
10.3390/cells9081766
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glutamine Addiction and Therapeutic Strategies in Lung Cancer
- (2019) Karolien Vanhove et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rac-Mediated Macropinocytosis of Extracellular Protein Promotes Glucose Independence in Non-Small Cell Lung Cancer
- (2019) Cindy Hodakoski et al. Cancers
- Mitochondrial GPT2 plays a pivotal role in metabolic adaptation to the perturbation of mitochondrial glutamine metabolism
- (2019) Minjoong Kim et al. ONCOGENE
- LKB1 and KEAP1/NRF2 pathways cooperatively promote metabolic reprogramming with enhanced glutamine dependence in KRAS-mutant lung adenocarcinoma
- (2019) Ana Galan-Cobo et al. CANCER RESEARCH
- Efficacy and safety of cycloserine-containing regimens in the treatment of multidrug-resistant tuberculosis: a nationwide retrospective cohort study in China
- (2019) Jing Wang et al. Infection and Drug Resistance
- Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis
- (2019) Benjamin L. Woolbright et al. MOLECULAR CANCER THERAPEUTICS
- T Cell Activation Depends on Extracellular Alanine
- (2019) Noga Ron-Harel et al. Cell Reports
- LKB1 deficiency renders non-small-cell lung cancer cells sensitive to ERK inhibitors.
- (2019) Elisa Caiola et al. Journal of Thoracic Oncology
- Recent Development of Small Molecule Glutaminase Inhibitors
- (2018) Minsoo Song et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach
- (2018) Elisa Caiola et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
- (2017) Rodrigo Romero et al. NATURE MEDICINE
- G48A, a New KRAS Mutation Found in Lung Adenocarcinoma
- (2016) Mirko Marabese et al. Journal of Thoracic Oncology
- Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion
- (2016) Cristovão M. Sousa et al. NATURE
- Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities
- (2016) Emma M. Kerr et al. NATURE
- Different metabolic responses to PI3K inhibition in NSCLC cells harboring wild-type and G12C mutant KRAS
- (2016) Elisa Caiola et al. Oncotarget
- Pyruvate carboxylase is critical for non–small-cell lung cancer proliferation
- (2015) Katherine Sellers et al. JOURNAL OF CLINICAL INVESTIGATION
- Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells
- (2015) Laura Brunelli et al. Oncotarget
- Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
- (2014) M. I. Gross et al. MOLECULAR CANCER THERAPEUTICS
- Altered Glutamine Metabolism and Therapeutic Opportunities for Lung Cancer
- (2013) Amr Mohamed et al. Clinical Lung Cancer
- Glutaminase regulation in cancer cells: a druggable chain of events
- (2013) William P. Katt et al. DRUG DISCOVERY TODAY
- Pyruvate carboxylase is required for glutamine-independent growth of tumor cells
- (2011) T. Cheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started